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Abstract
Although risk factors for multi-drug resistant tuberculosis are known, few studies have differ-
entiated between acquired and transmitted resistance. It is important to identify factors
associated with these different mechanisms to optimize control measures. We conducted
a prospective cohort study of index TB patients and their household contacts in Lima, Peru
to identify risk factors associated with acquired and transmitted resistance, respectively.
Patients with higher socioeconomic status (SES) had a 3-fold increased risk of transmitted
resistance compared to those with lower SES when acquired resistance served as the
baseline. Quality of housing mediated most of the impact of SES.
Introduction
The new Post-2015 Global Tuberculosis Strategy identifies action on social determinants of
tuberculosis as a main component of the bold policies and supportive systems required for TB
control. In line with this Strategy, there is a general agreement that research is needed to assess
and measure how social determinants affect TB risk [1].
At the population-level, improved socioeconomic conditions have been accompanied by a
decline in the tuberculosis burden in industrialized countries over the past century. However,
the association between socioeconomic status (SES) and TB is mediated by different proximal
risk factors operating at different points in the natural history of TB [2,3]. The magnitude and
direction of the association may therefore vary by setting, study population and the clinical fea-
tures of the disease [3].
Scant data are available on the association between SES and multidrug-resistant tuberculosis
(MDR-TB). Drug-resistant TB can result from two mechanisms: i) the selection for resistant
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bacteria in a patient undergoing treatment—defined as acquired (or secondary) resistance,
or ii) infection with a drug resistant strain, defined as transmitted (or primary) resistance.
Although previous studies have identified risk factors for MDR-TB [4,5], few studies have dif-
ferentiated between risk factors for acquired and transmitted resistance or elucidated the role
of SES in these two mechanisms.
Distinguishing between risk factors for acquired and those for transmitted MDR-TB may
provide useful evidence to plan, implement, and evaluate targeted, preventive interventions
in the context of TB control programs. Here, we analyze the relationship between individual
and household-level SES and behavioral factors and acquired and transmittedMDR-TB in an
urban South American setting.
Methods
Ethics Statement
The study was reviewed and approved by two IRBs. The first is the Research Ethics Committee
of the National Institute of Health of Peru in Lima, Peru. The second is the Office of Human
Research Administration at the Harvard School of Public Health.
Written informed consent was obtained from subjects older than 18 years old included in
the study and from the guardians of subjects included in the study who were age 16–17 years.
Study Population
We conducted a prospective cohort study on the epidemiology of MDR tuberculosis in urban
Lima, Peru [6]. The primary objectives of the study were to measure the transmissibility of DR
TB compared to drug-sensitive(DS) TB and to identify host and environmental factors associ-
ated with developing TB infection and disease. The study population comprised index TB
patients>16 years diagnosed by the Peruvian National TB program in all outpatient public
health centers of 23 urban districts and their household contacts. Individual written consent
was sought from all subjects included in the study.
Data
For each case, we collected data on demographic and SES characteristics, TB history and clini-
cal status using clinical records and standardized questionnaires administered in-person by
trained study workers. Sputum microscopy, mycobacterial cultures and first-line drug sensitiv-
ity tests were performed on samples collected for all patients. Mycobacterium tuberculosis
(Mtb) strains were genotyped using 24-loci mycobacterial interspersed repeats (MIRU) and
variable-number tandem repeats(VNTR) using standard methods [7]. Patients were started on
treatment at the time of diagnosis and sputum smear. Cultures and drug resistance testing
were repeated for patients with DS TB at 2 and 6 months and at 2, 6, 12, and 18 months for
those who had MDR-TB.
Definitions
We adopted a conservative approach to define acquired and transmitted resistance. In the
past, a history of previous TB treatment in patients with DR TB has been used as a proxy for
acquired resistance. However, ‘previously treated’DR patients may include not only those who
acquire resistance during previous treatment but also those who were primarily infected or re-
infected with resistant strains. Along those lines, whether to consider ‘previous TB treatment’ as
a proxy for acquired TB resistance has been debated in the literature and proved to fail to cor-
rectly identify subjects with acquired drug resistance [2–4]. To avoid potential misclassification,
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we classified a patient as having acquiredDR only if 1)he/she was initially diagnosed with DS
tuberculosis at study enrollment and later developed microbiologically confirmed resistance to
any TB drug and if 2)his/her DS and subsequent DRMtb isolates shared the sameMIRU-based
genotype. We considered a patient to harbor a transmittedMDR strain if his or her initial isolate
was MDR and it shared a genotype with a strain from at least one other study participant and if
all the other strains within a cluster of shared strains were multi-drug resistant. We considered
study participants to be part of a cluster if the Mtb strain with which they were infected shared
identical patterns for 24 loci VNTR-MIRU with one or more other isolated strains [8].
Exposures of Interest and Principal Component Analysis
To assess the contribution of social determinants to DR risk, we considered individual-level
proximal risk factors including smoking, drinking habits, and a history of imprisonment as
well as distal determinants including education and household-level socioeconomic status
(SES). All available household-level socioeconomic variables including housing quality water
supply and sanitation data were included in a principal component analysis(PCA) to derive a
measure of household-level SES(S1 Table)[9]. PCA is a common approach for generating
wealth indices based on household asset information. PCA is a data reduction statistical tech-
nique that extracts a set of uncorrelated ‘principal components’ from a set of correlated vari-
ables, where each principal component is a weighted linear combination of the original
variables. The weights (S1 Table) of the first principal component—which corresponds to the
combination of the variables that explains the highest proportion of the variance—were used
to generate a composite SES score as a continuous variable. The properties of the SES score
were explored through histograms to verify the assumption of uniform distribution among the
study population. The SES score was categorized into tertiles corresponding to relative “low, ”
“middle, ” and “upper” SES. To explore the possible mediation pathway between SES and the
defined outcomes, the variables used to compute the SES were also considered as separate
exposures in sensitivity analyses.
Analysis
We compared the distribution of exposures between subjects with transmitted and acquired
DR TB reporting unadjusted and adjusted odds ratios(ORs); 95% confidence intervals(95%CI)
were derived from univariate and multivariate logistic regression. Odds ratios for potential risk
factors for transmitted resistance contrasted the odds of exposure in MDR-TB subjects with
transmitted resistance with the odds of that exposure among subjects with acquired drug resis-
tance. The final model was built on the basis of a conceptual framework derived from the litera-
ture describing the association between TB disease and SES, adapted to the study setting
[10,11]. It included the covariates age, sex, education level, history of imprisonment, smoking,
and drinking.
Results
Between October 2009 and August 2012, we identified 3379 cases of culture-confirmed TB of
which 411(12%) had at least one multi-drug resistant Mtb isolate at some point during the
study. 29 subjects met our definition for acquired resistance and 61 for transmitted resistance.
The remaining MDR cases could not be classified as having acquired or transmitted resistance
based on these criteria.
Table 1 describes the characteristics of MDR patients by acquired, transmitted and unclassi-
fied status. Socioeconomic status was not differentially distributed between MDR-TB subjects
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included and excluded from our analysis (p = 0.7), nor were the other considered variables
(Table 1).
In the univariate analyses, subjects with transmitted resistance were younger, of higher
socioeconomic status, more educated, more likely to have a history of incarceration or to be
heavy drinkers than those with acquired resistance, although only age met the p = .05 criteria
for statistical significance. After adjustment for age, sex and socioeconomic variables in the
final model(Table 1), participants of “medium” and “high” SES were 1.31(95%CI:0.37–4.64)
and 3.15(95%CI: 0.81–12.18) times as likely to have transmitted compared to acquired resis-
tance (p for trend = 0.08). When we conducted a sensitivity analysis that considered housing
alone among the SES variables, we found that participants with transmitted resistance were
3.18(95%CI: 1.10–9.58) more likely to have better housing than those with acquired resistance.
Discussion
Our results suggest that in urban Lima higher socioeconomic status is associated with a nearly
3-fold increased risk of transmitted compared to acquired resistance and, conversely, that
lower socioeconomic status is associated with an increased risk of acquired resistance. Quality
of housing mediates most of the impact of SES. Despite this suggestive evidence, the results
do not allow us to determine whether this effect is due to an increased risk of transmitted
Table 1. Socio-economic risk factors for acquired and transmitted resistance.
ACQUIRED TRANSMITTED Unclassiﬁed
MDR-TB cases
Unadjusted Adjusted for
age and sex
Final model
(n = 29) (n = 61) (n = 324) OR (95%CI) OR (95%CI) OR (95%CI)
no.(%) no.(%) no.(%)
Education
Less than high
school
13 (44.83) 23 (37.7) 119 (36.7) 1 1 1
High school
completed or more
16 (55.17) 38 (62.3) 205 (63.3) 1.34 (0.55–3.29) 1.18 (0.46–3.0) 0.63 (0.22–1.89)a p = 0.41
Prisona
No 28 (96.55) 53 (86.89) 291 (89.8) 1 1 1
Yes 1 (3.45) 3 (4.92) 27 (8.3) 1.21 (0.54–2.72) 1.26 (0.47–3.36) 1.26 (0.45–3.51) a p = 0.6
missing - 5 (8.2) 6 (1.9)
Smoking habit
Non-Smoker 27 (93.1) 56 (91.80) 301 (92.9) 1 1 1
Smoker 2 (6.9) 2 (3.28) 16 (4.9) 1.58 (0.16–15.95) 2.46 (0.22–26.7) 1.27 (0.79–20.53) a p = 0.86
missing - 3 (4.92) 7 (2.2)
Drinking habit
Non heavy drinker 26 (89.66) 49 (80.33) 265 (81.8) 1 1 1
Heavy drinker 3 (10.34) 11 (18.03) 54 (16.7) 1.95 (0.5–7.6) 1.85 (0.46–7.45) 2.10 (0.39–10.90) a p = 0.38
missing - 1 (1.64) 5 (1.5)
SES status
Low 10 (34.48) 18 (29.51) 117 (36.1) 1 1 1
Medium 10 (34.48) 16 (26.23) 113 (34.9) 0.89 (0.29–2.68) 1.19 (0.36–3.87) 1.31 (0.37–4.64) a p = 0.08
(trend)
High 9 (31.03) 24 (39.34) 90 (27.8) 1.48 (0.50–4.40) 1.85 (0.59–5.76) 3.15 (0.81–12.18) a
missing - 3 (4.92) 4 (1.2)
a adjusted for: age, sex, education, prison, smoking, drinking habit and SES status -
doi:10.1371/journal.pone.0146642.t001
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resistance in subjects of higher SES or an increased risk of acquired resistance in subjects of
lower SES (although the distribution of SES status among the cases suggests the former) and
we cannot quantify how much socioeconomic vulnerability contributes to MDR-TB burden
through either mechanism.
One possible interpretation of our results is that better houses—where walls, roofs and win-
dows are built with more solid materials—are less well ventilated and therefore increase the
risk of within-household transmission. It is also possible that those of higher SES status work
less and spend more time at home, thereby increasing their exposure within a household.
Another possible pathway is that those with better houses may spend more time socializing
indoors with increased risk of household crowding. On the other hand, wealthier people might
have better access to healthcare, earlier access to TB diagnosis and supports permitting better
treatment compliance, this reducing the risk of acquiring drug resistance. Case detection rates
may also vary by SES strata and this might bias the results; although Peru has a strong public
National TB Program that captures most cases, we cannot exclude this possibility in our study
setting.
Our findings extend to transmitted MDR-TB the results of several studies from Africa
which reported an unexpected association between measures of relative wealth and TB. Two
consecutive cohorts in Malawi found that subjects living in higher quality houses were at
higher risk of TB [10] while other measures of SES such as asset ownership were associated
with diminished risk [10]. Similar findings have been reported from both high and low-inci-
dence TB settings.
A large literature is available on how to measure socioeconomic status in relation to health
outcomes [12]. Different socioeconomic measures capture different pathways of the association
between socioeconomic status and tuberculosis. The rationale for using principal component
analysis to derive a composite measure of relative socioeconomic status was to apply a recog-
nized and increasingly used statistical technique and to obtain results easily comparable to
other settings’ findings. We have previously applied the same analytical technique to explore
the role of proximal risk factors in the relationship between TB and poverty in other settings
[13].
The clustering definition we applied was supported by recent findings that demonstrated
fully identical 24 loci VNTR typing result to be the most appropriate cluster definition in TB
control practice [8].
Our work has some limitations. The conservative case definitions we adopted excluded
most of the MDR-TB cases recruited in the cohort and we were therefore not able to assess the
relative contribution of the two mechanisms to the MDR-TB burden in the study setting. Con-
sequently, our small sample size did not allow us to identify any other than the most extreme
associations and null findings should not be interpreted to suggest that other risk factors had
no effect. Despite the limitations for statistical inference with small sample sizes, the p-value of
.08 is weakly significant. Our strict definitions to differentiate between acquired and transmit-
ted MDR-TB cases that combined both epidemiological and molecular features adds to the
body of knowledge on the topic available in the literature and is one of the strengths of our
study. A second limitation is that our findings do not allow us to derive conclusions generaliz-
able to the entire Lima population; still, they allow us to suggest—on the basis of rigorously
conducted analysis—that acquired and transmittedMDR-TB are associated with different risk
factors that need to be taken into account when planning and implementing control pro-
grammes and interventions [14]. A third limitation, addressed above, is that we were unable to
distinguish between the scenario in which higher SES facilitate transmission of MDR TB and
that in which lower SES enabled acquisition of MDR TB.
Drug Resistance and Socioeconomic Status
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To our knowledge this is the first study to assess the association between SES and MDR-TB
distinguishing between acquired and transmitted resistance, especially using a prospective
design and rigorous definitions that create more certainty about the classification of MDR TB
into these categories. In particular, scant evidence is available on whether specific social deter-
minants are proxies for exposure to patients with drug-resistant TB [15], or instead are associ-
ated with suboptimal care that selects for drug resistance. In the past, a history of previous TB
treatment in drug resistant TB patients was used as a proxy for acquired resistance. However,
because the ‘previously treated’ patient category can comprise patients primarily infected or re-
infected with resistant strains, this approach may not reliably identify subjects with acquired
drug resistance. Molecular epidemiologic approaches have sometime been used to differentiate
between primary and secondary resistance; here, investigators have assumed that clustered
MDR cases are those with primary resistance and those that are not clustered are due to
acquired resistance. Like other molecular epidemiologic studies, however, the validity of this
approach depends on the completeness of sampling and errors often results from convenience
or small samples [16].
As stated in the recently released Global Tuberculosis Report—selected risk factors, includ-
ing the emergence of DR and MDR tuberculosis poses a significant threat to global tuberculosis
control strategies [17,18,19,20]. Acquired and transmitted resistance arise from two different
mechanisms that are associated with different risk factors. We analyzed data from a large-scale
prospective study and provide evidence suggesting that better living conditions might be asso-
ciated with increased risk of MDR-TB transmission in urban settings. Health education pro-
grams should target specific subgroups of the population, promote good ventilation and
prompt healthcare seeking and diagnosis so as to interrupt TB transmission. Further research
is needed to confirm our findings. Our next step will be to geo-reference TB cases to explore
the impact of ecological-level factors on MDR-TB transmission.
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